|Articles|December 16, 2020

Applied Clinical Trials, December 2020 Issue (PDF)

Click the title above for a link to open the Applied Clinical Trials December 2020 issue in an interactive PDF format.

Click cover for PDF

Articles in this issue

almost 5 years ago

Article

E6 (R3) on Horizon

almost 5 years ago

Article

Pandemic Shines Spotlight on Clinical Trial Conduct and Regulation in 2020

almost 5 years ago

Article

Industry Forced to Rethink Patient Participation in Trials

almost 5 years ago

Article

Top 5 Global Clinical Trial Disclosure Changes in 2020 Amidst Pandemic

almost 5 years ago

Article

Managing Risks in Clinical Trials During a Pandemic with ICH E6 (R2)

almost 5 years ago

Article

Importance of Diversity in Parkinson’s Research

almost 5 years ago

Article

Regulatory Data: How Technology Can Help ClinOps Survive

almost 5 years ago

Article

Decentralized Trials, Pros and Cons

almost 5 years ago

Article

Public Trust and the ‘Last Mile’ for COVID-19 Vaccines

almost 5 years ago

Article

The Ever-Changing Face of NICE Guidance on Drug Innovation

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome

ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research

Atom Therapeutics Launches Global Phase II Trial of Novel Anti-Inflammatory Treatment for Acute Gout Flares

Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease

© 2025 MJH Life Sciences^®

All rights reserved.